Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The daily Top 10 COVID papers


  Free Subscription


1 J Clin Psychiatry
3 Mol Psychiatry
1 Neurosci Lett
1 Pharmacopsychiatry
1 PLoS One
3 Psychiatry Res
5 Psychol Med
22 Schizophr Res

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles


  1. KILLASPY H, Baird G, Bromham N, Bennett A, et al
    Rehabilitation for adults with complex psychosis: summary of NICE guidance.
    BMJ. 2021;372:n1.

    J Clin Psychiatry

  2. KIM S, Kim S, Koh M, Choi G, et al
    Effects of Long-Acting Injectable Paliperidone Palmitate on Clinical and Functional Outcomes in Patients With Schizophrenia Based on Illness Duration.
    J Clin Psychiatry. 2021;82.
    PubMed         Abstract available

    Mol Psychiatry

  3. ROESKE MJ, McHugo M, Vandekar S, Blackford JU, et al
    Incomplete hippocampal inversion in schizophrenia: prevalence, severity, and impact on hippocampal structure.
    Mol Psychiatry. 2021 Jan 12. pii: 10.1038/s41380-020-01010.
    PubMed         Abstract available

    The genetics of bipolar disorder.
    Mol Psychiatry. 2020;25:544-559.
    PubMed         Abstract available

  5. SONDERBY IE, Gustafsson O, Doan NT, Hibar DP, et al
    Dose response of the 16p11.2 distal copy number variant on intracranial volume and basal ganglia.
    Mol Psychiatry. 2020;25:584-602.
    PubMed         Abstract available

    Neurosci Lett

  6. MATAS E, William Deakin JF, Toro CT
    Abnormal Expression of Post-Synaptic Proteins in Prefrontal Cortex of Patients with Schizophrenia.
    Neurosci Lett. 2021 Jan 10:135629. doi: 10.1016/j.neulet.2021.135629.
    PubMed         Abstract available


  7. SAKURAI H, Yasui-Furukori N, Suzuki T, Uchida H, et al
    Pharmacological Treatment of Schizophrenia: Japanese Expert Consensus.
    Pharmacopsychiatry. 2021 Jan 12. doi: 10.1055/a-1324-3517.
    PubMed         Abstract available

    PLoS One

  8. REEVE S, Sheaves B, Freeman D
    Excessive sleepiness in patients with psychosis: An initial investigation.
    PLoS One. 2021;16:e0245301.
    PubMed         Abstract available

    Psychiatry Res

  9. MARTINI F, Spangaro M, Buonocore M, Bechi M, et al
    Clozapine tolerability in Treatment Resistant Schizophrenia: exploring the role of sex.
    Psychiatry Res. 2020;297:113698.
    PubMed         Abstract available

  10. DADA O, Adanty C, Dai N, Jeremian R, et al
    Biological aging in schizophrenia and psychosis severity: DNA methylation analysis.
    Psychiatry Res. 2020;296:113646.
    PubMed         Abstract available

  11. SERRA-MAYORAL A, Mareca C, Cano R, Romaguera A, et al
    The BAT: A videotaped battery to assess theory of mind in schizophrenia.
    Psychiatry Res. 2021;297:113709.
    PubMed         Abstract available

    Psychol Med

  12. RINGIN E, Cropley V, Zalesky A, Bruggemann J, et al
    The impact of smoking status on cognition and brain morphology in schizophrenia spectrum disorders.
    Psychol Med. 2021 Jan 14:1-19. doi: 10.1017/S0033291720005152.
    PubMed         Abstract available

  13. MOORE TM, Calkins ME, Rosen AFG, Butler ER, et al
    Development of a probability calculator for psychosis risk in children, adolescents, and young adults.
    Psychol Med. 2021 Jan 12:1-9. doi: 10.1017/S0033291720005231.
    PubMed         Abstract available

  14. MEYER N, Joyce DW, Karr C, de Vos M, et al
    The temporal dynamics of sleep disturbance and psychopathology in psychosis: a digital sampling study.
    Psychol Med. 2021 Jan 12:1-10. doi: 10.1017/S0033291720004857.
    PubMed         Abstract available

    The social defeat hypothesis of schizophrenia is more topical than ever. Reply to Schalbroeck.
    Psychol Med. 2021 Jan 12:1-2. doi: 10.1017/S0033291720005176.

  16. LIU N, Lencer R, Yang Z, Zhang W, et al
    Altered functional synchrony between gray and white matter as a novel indicator of brain system dysconnectivity in schizophrenia.
    Psychol Med. 2021 Jan 13:1-9. doi: 10.1017/S0033291720004420.
    PubMed         Abstract available

    Schizophr Res

  17. BOGE K, Hahne I, Bergmann N, Wingenfeld K, et al
    Mindfulness-based group therapy for in-patients with schizophrenia spectrum disorders - Feasibility, acceptability, and preliminary outcomes of a rater-blinded randomized controlled trial.
    Schizophr Res. 2021;228:134-144.
    PubMed         Abstract available

  18. SCHOONOVER KE, Roberts RC
    Markers of copper transport in the cingulum bundle in schizophrenia.
    Schizophr Res. 2021;228:124-133.
    PubMed         Abstract available

  19. HEDBERG M, Imbeault S, Erhardt S, Schwieler L, et al
    Disrupted sensorimotor gating in first-episode psychosis patients is not affected by short-term antipsychotic treatment.
    Schizophr Res. 2021;228:118-123.
    PubMed         Abstract available

  20. VILA-BADIA R, Butjosa A, Del Cacho N, Serra-Arumi C, et al
    Types, prevalence and gender differences of childhood trauma in first-episode psychosis. What is the evidence that childhood trauma is related to symptoms and functional outcomes in first episode psychosis? A systematic review.
    Schizophr Res. 2021;228:159-179.
    PubMed         Abstract available

  21. SENDI MSE, Pearlson GD, Mathalon DH, Ford JM, et al
    Multiple overlapping dynamic patterns of the visual sensory network in schizophrenia.
    Schizophr Res. 2021;228:103-111.
    PubMed         Abstract available

  22. SMESNY S, Berberich D, Gussew A, Schonfeld N, et al
    Alterations of neurometabolism in the dorsolateral prefrontal cortex and thalamus in transition to psychosis patients change under treatment as usual - A two years follow-up (1)H/(31)P-MR-spectroscopy study.
    Schizophr Res. 2021;228:7-18.
    PubMed         Abstract available

  23. SECCOMANDI B, Agbedjro D, Bell M, Keefe RSE, et al
    Exploring the role of age as a moderator of cognitive remediation for people with schizophrenia.
    Schizophr Res. 2021;228:29-35.
    PubMed         Abstract available

  24. KIMURA M, Oda Y, Oishi K, Yoshino K, et al
    Effects of repeated electroconvulsive shocks on dopamine supersensitivity psychosis model rats.
    Schizophr Res. 2021;228:1-6.
    PubMed         Abstract available

  25. VELLIGAN DI, Maples NJ, Pokorny JJ, Wright C, et al
    Assessment of adherence to oral antipsychotic medications: What has changed over the past decade?
    Schizophr Res. 2020;215:17-24.
    PubMed         Abstract available

  26. SPARK J, Gaweda L, Allott K, Hartmann JA, et al
    Distinguishing schizophrenia spectrum from non-spectrum disorders among young patients with first episode psychosis and at high clinical risk: The role of basic self-disturbance and neurocognition.
    Schizophr Res. 2021;228:19-28.
    PubMed         Abstract available

  27. ZHANG Y, Geyfman A, Coffman B, Gill K, et al
    Distinct alterations in resting-state electroencephalogram during eyes closed and eyes open and between morning and evening are present in first-episode psychosis patients.
    Schizophr Res. 2021;228:36-42.
    PubMed         Abstract available

  28. LINCOLN SH, Johnson T, Winters A, Laquidara J, et al
    Social exclusion and rejection across the psychosis spectrum: A systematic review of empirical research.
    Schizophr Res. 2021;228:43-50.
    PubMed         Abstract available

  29. DICKERSON F, Katsafanas E, Origoni A, Squire A, et al
    Exposure to Epstein Barr virus and cognitive functioning in individuals with schizophrenia.
    Schizophr Res. 2021;228:193-197.
    PubMed         Abstract available

  30. BIGSETH TT, Fredriksen M, Egeland J, Andersen E, et al
    Elevated levels of soluble urokinase plasminogen activator receptor as a low-grade inflammation marker in schizophrenia: A case-control study.
    Schizophr Res. 2021;228:190-192.

  31. ADDINGTON J, Santesteban-Echarri O, Braun A, Lecomte T, et al
    Assessing social functioning in youth at clinical high-risk for psychosis.
    Schizophr Res. 2021;228:188-189.

  32. SZESZKO PR, McNamara RK, Gallego JA, Malhotra AK, et al
    Longitudinal investigation of the relationship between omega-3 polyunsaturated fatty acids and neuropsychological functioning in recent-onset psychosis: A randomized clinical trial.
    Schizophr Res. 2021;228:180-187.
    PubMed         Abstract available

  33. POPE LG, Manseau MW, Kelley ME, Compton MT, et al
    Symptomatology and neurocognition among first-episode psychosis patients with and without cannabis use in the three months prior to first hospitalization.
    Schizophr Res. 2021;228:83-88.
    PubMed         Abstract available

  34. SCHOONOVER KE, Farmer CB, Morgan CJ, Sinha V, et al
    Abnormalities in the copper transporter CTR1 in postmortem hippocampus in schizophrenia: A subregion and laminar analysis.
    Schizophr Res. 2021;228:60-73.
    PubMed         Abstract available

  35. MUKKU SSR, Nadella RK, Sivakumar PT, Sinha P, et al
    Is late onset schizophrenia a forerunner of Frontotemporal dementia? - A case series.
    Schizophr Res. 2021;228:56-57.

  36. PENNEY D, El-Baalbaki G, Lepage M
    Prevalence and severity of posttraumatic stress symptoms in psychosis: Associations with affective and patient-centered variables in those referred for psychological services.
    Schizophr Res. 2021;228:53-55.

  37. ABPLANALP SJ, Gold A, Gonzalez R, Doshi S, et al
    Feasibility of using smartphones to capture speech during social interactions in schizophrenia.
    Schizophr Res. 2021;228:51-52.

  38. ALLE MC, Berna F, Danion JM, Berntsen D, et al
    Unraveling the role of retrieval deficits in autobiographical memory impairment in schizophrenia: A comparison of involuntary and voluntary autobiographical memories.
    Schizophr Res. 2021;228:89-96.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Schizophrenia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.